Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
13.35
-0.41 (-2.98%)
Oct 29, 2025, 10:46 AM EDT - Market open
Pharming Group Employees
Pharming Group had 404 employees as of December 31, 2024. The number of employees increased by 22 or 5.76% compared to the previous year.
Employees
404
Change (1Y)
22
Growth (1Y)
5.76%
Revenue / Employee
$841,178
Profits / Employee
-$20,297
Market Cap
917.95M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 404 | 22 | 5.76% |
| Dec 31, 2023 | 382 | 50 | 15.06% |
| Dec 31, 2022 | 332 | 55 | 19.86% |
| Dec 31, 2021 | 277 | 15 | 5.73% |
| Dec 31, 2020 | 262 | 50 | 23.58% |
| Jan 1, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PHAR News
- 6 days ago - Pharming Group to report third quarter 2025 financial results and provide business update on November 6 - GlobeNewsWire
- 9 days ago - Pharming Group announces presentations at 2025 ACAAI Annual Scientific Meeting showcasing new data across rare disease portfolio - GlobeNewsWire
- 22 days ago - Pharming Group provides update on previously announced G&A expense reduction plan - GlobeNewsWire
- 4 weeks ago - Pharming Group announces U.S. FDA acceptance and Priority Review of supplemental New Drug Application for leniolisib in children with APDS aged 4 to 11 years - GlobeNewsWire
- 7 weeks ago - Pharming Group promoted to the Euronext AMX® index - GlobeNewsWire
- 2 months ago - Pharming Group to present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 2 months ago - Pharming Group appoints Kenneth Lynard as Chief Financial Officer - GlobeNewsWire
- 3 months ago - Pharming Group to participate in August investor conference - GlobeNewsWire